Caption Management’s AbbVie ABBV Stock Holding History

Caption Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.33M	Buy	33,700 +17,600	+109%	+$3.9M	0.04%	417
2025 Q4	$3.68M	Buy	+16,100	New	+$3.67M	0.03%	607
2024 Q1	–	Sell	-29,700	Closed	-$5.12M	–	1127
2023 Q4	$4.6M	Buy	29,700 +26,000	+703%	+$3.79M	0.06%	366
2023 Q3	$552K	Buy	+3,700	New	+$543K	0.01%	913
2022 Q1	–	Sell	-75,500	Closed	-$11M	–	1405
2021 Q4	$10.2M	Buy	75,500 +57,500	+319%	+$6.79M	0.11%	228
2021 Q3	$1.94M	Buy	+18,000	New	+$2.06M	0.02%	770
2021 Q1	–	Sell	-44,300	Closed	-$4.75M	–	994
2020 Q4	$4.75M	Buy	+44,300	New	+$4.26M	0.11%	236
2019 Q2	–	Sell	-25,000	Closed	-$1.96M	–	641
2019 Q1	$2.02M	Buy	+25,000	New	+$2.05M	0.11%	236

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caption Management's ABBV Position: Q1 2026 in Review

Caption Management increased its AbbVie (ABBV) stake by 109% in Q1 2026, buying an estimated $3.9M and bringing the position to 33,700 shares worth $7.33M. The position accounts for 0.04% of the portfolio, ranked #417.

Caption Management first reported a position in ABBV in Q1 2019 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2021. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Caption Management held 33,700 shares of AbbVie worth $7.33M as of Q1 2026.
Caption Management bought 17,600 AbbVie shares in Q1 2026, an estimated $3.9M.
AbbVie made up 0.04% of Caption Management's portfolio in Q1 2026, its #417 holding.
Caption Management first reported a position in AbbVie in Q1 2019 and has held it in 8 quarters since.
Caption Management's AbbVie position peaked at $10.2M in Q4 2021.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.